Marianne Mancini's most recent trade in Viking Therapeutics Inc was a trade of 90,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 4, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | Marianne Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianne Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 73,000 | 167,655 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianne Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 6,750 | 174,405 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianne Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.80 per share. | 04 Jan 2021 | 2,773 | 171,632 (0%) | 0% | 5.8 | 16,083 | Common Stock, par value $0.00001 per share |